Introduction:
During worsening heart failure (HF), it is unknown whether clinical features differ according to the level of vascular expansion, and how changes in serum substance(s) are associated with volume changes.
Hypothesis:
Changes in serum solutes/albumin are associated with vascular expansion and induce different clinical features during HF worsening.
Methods:
Data from 47 HF patients that experienced a worsening HF episode were analyzed. Each patient had at least 2 of the following HF signs: S3, rales, leg edema, body weight (BW) gain (≥1.5 kg), and ultrasound pleural effusion. Blood tests included hemoglobin (Hb), hematocrit (Ht), albumin, solutes [sodium (Na), potassium, chlorine (Cl), blood urea nitrogen, creatinine (Cr), and uric acid], and b-type natriuretic peptide (BNP). The relative change in the vascular expansion from stable to worsening HF was estimated based on changes in the plasma volume (%PV) as follows: 100 x {Hb (stable) x [1-Ht (worse)]}/ {Hb (worse) x [1-Ht (stable)]}-100.
Results:
When divided into two groups by the median %PV, the clinical features of the expansion group [11≤%PV (range 11 to 36%); n=24] had a lower incidence of rales (13 vs 52%, p=0.005) and a tendency toward preserved renal function defined by a decrease in serum Cr (83 vs 57%, p=0.06) as compared with the non-expansion group [%PV (range -19 to 10.8%)<11;n= 23], though the increase in BW and log BNP did not differ between groups. The expansion group had a greater increase in serum Na (3.58±4.43 vs -0.11±3.31mEq, p=0.0016) and Cl (5.54±6.24 vs -0.03±4.18, p=0.0006), and a greater decrease in albumin (-0.37±0.3 vs -0.16±0.3, p=0.04) from stability to worsening HF. Logistic regression analysis revealed an independent association between the increase in %PV and the increase in the serum Cl concentration from stability to HF worsening (OR:12.5, 95%CI: 1.89-82, P=0.009).
Conclusions:
Vascular expansion during worsening HF is associated with changes in the serum Cl concentration. As a key osmolyte, greater accumulation of this solute in the blood vessels might act to increase or maintain intravascular volume, which induces different clinical features of HF, such as a lower incidence of rales and preserved renal function due to maintenance of the blood supply to the kidney.